ReviewJournal of ovarian research2026
A review of the association between abnormal body mass index and oocyte quality.
Review in Journal of ovarian research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
In recent years, the global prevalence of obesity has witnessed a sharp increase. Abnormal body mass index (BMI) exerts a profound influence on female fertility, particularly on oocyte quality. This review systematically summarizes the correlation between abnormal BMI and oocyte quality. It focuses on the mechanisms through which obesity impairs oocytes by disrupting lipid metabolism, energy supply, oxidative stress, DNA damage and repair, as well as epigenetic regulation. Obesity disrupts lipid homeostasis in follicular fluid, thereby inducing lipotoxicity. It damages mitochondria and the endoplasmic reticulum, resulting in insufficient energy production. It triggers excessive oxidative stress, which impairs mitochondrial DNA integrity and meiosis. It aggravates DNA damage while weakening the repair capacity, and disturbs DNA methylation and histone modifications, thus posing a threat to oocyte genomic stability and the developmental health of offspring. Although low BMI is also associated with poor oocyte quality, relevant studies are scarce, limiting the coverage of low BMI in this review. Clinically, abnormal BMI reduces the rates of implantation and live birth and increases the risk of miscarriage. Future research ought to focus on the mechanisms by which obesity and underweight affect oocyte quality, formulate targeted interventions like weight management and antioxidant therapy, and refine personalized assisted reproductive strategies to enhance the reproductive outcomes of women with abnormal BMI.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.